Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
95.383,27
-1,88%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Mind Medicine MindMed Inc (MNMD) Mind Medicine MindMed Inc (MNMD) Notizie

Mind Medicine MindMed Inc

MNMD
7,16
0,145 (2,07%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/12/202413:00BWMindMed to Be Added to the Nasdaq Biotechnology Index
16/12/202413:30EDGAR2Form 8-K - Current report
16/12/202413:00BWMindMed Announces First Patient Dosed in Phase 3 Voyage..
11/12/202413:00BWMindMed Scientific Presentations at American College of..
05/12/202413:00BWMindMed Awarded Innovation Passport Designation by the..
03/12/202413:00BWMindMed Appoints Javier Muniz, M.D., as Vice President of..
02/12/202413:00BWMindMed Announces New Employee Inducement Grants
18/11/202413:00BWMindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and..
14/11/202422:05EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202413:00BWMindMed to Participate in Upcoming Investor Conferences
08/11/202420:17EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
07/11/202422:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:15EDGAR2Form 8-K - Current report
07/11/202422:01BWMindMed Reports Third Quarter 2024 Financial Results and..
24/10/202413:00BWMindMed to Host Conference Call and Webcast to Discuss Third..
22/10/202422:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
17/10/202422:18EDGAR2Form 8-K - Current report
17/10/202422:10EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
26/9/202402:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202402:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202402:29EDGAR2Form 144 - Report of proposed sale of securities
26/9/202402:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202402:27EDGAR2Form 144 - Report of proposed sale of securities
09/9/202422:01BWMindMed Announces New Employee Inducement Grants
04/9/202413:00BWMindMed to Participate in September Investor Conferences
22/8/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202403:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202413:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202413:15EDGAR2Form 8-K - Current report
13/8/202413:00BWMindMed Reports Second Quarter 2024 Financial Results and..
13/8/202411:45IHMARKETNEWSU.S. Futures Climb Before Inflation Data; Oil Slips on OPEC..
12/8/202414:38EDGAR2Form 8-K - Current report
12/8/202412:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/8/202414:44BWMind Medicine (MindMed) Inc. Announces Pricing of Public..
09/8/202412:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/8/202412:00BWMind Medicine (MindMed) Inc. Announces Proposed Public..
06/8/202422:01BWMindMed to Present at Canaccord Genuity’s 44th Annual Growth..
06/8/202413:00BWMindMed to Host Conference Call and Webcast to Discuss..
29/7/202413:00BWMindMed Appoints Stephanie Fagan as Chief Corporate Affairs..
17/7/202413:00BWMindMed Announces Issuance of New Patent for MM120 Orally..
28/6/202413:00BWMindMed to be Included in Russell 2000® and Russell 3000®..
21/6/202413:00BWMindMed to Present at the H.C. Wainwright 5th Annual Neuro..
20/6/202414:00EDGAR2Form 8-K - Current report
20/6/202413:00BWMindMed Announces Constructive End-of-Phase 2 Meeting with..
11/6/202422:30EDGAR2Form 8-K - Current report
28/5/202413:00BWMindMed to Participate in June Conferences
09/5/202422:01BWMindMed to Participate at May Investor Conferences
09/5/202414:00BWNew Studies Presented at the International Society for..
08/5/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:10EDGAR2Form 8-K - Current report
Apertura: 6,96 Min: 6,9225 Max: 7,355
Chiusura: 7,015

La tua Cronologia

NASDAQ
MNMD
Mind Medicine MindMed
BIT
P1JUG7
BNP Paribas Issuance
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network